<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04143100</url>
  </required_header>
  <id_info>
    <org_study_id>19-06020314</org_study_id>
    <nct_id>NCT04143100</nct_id>
  </id_info>
  <brief_title>Anxiety and Symptom Burden in Hemodialysis Patients</brief_title>
  <official_title>Anxiety, Symptom Burden, and Dialysis Adherence in In-center Hemodialysis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Rogosin Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Rogosin Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anxiety has been identified as a prevalent and significant co-morbid condition in patients
      with End Stage Renal Disease (ESRD) being treated with hemodialysis. In particular, anxious
      sensitivity to symptoms commonly experienced by dialysis patients may lead patients to
      prematurely terminate their dialysis sessions and may have consequences on their dialysis
      adequacy and overall quality of life.

      The proposed study will examine the relationships between anxiety, depression, quality of
      life, symptom burden and dialysis prescription adherence. The primary regression analyses
      will be used to predict the influence of anxiety and depression (independently and together)
      on measures of adherence behaviors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Additional analyses will examine the relationship of elevated anxiety and depression scores
      on symptom burden, QOL, and other measures of dialysis adherence. Retrospective data of the
      preceding three months will be used to calculate measures of dialysis adherence (shortening
      and skipping) and clinical parameters.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 30, 2019</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Generalized Anxiety Disorder-7 (GAD-7)</measure>
    <time_frame>This is a cross-sectional study, with anxiety scores being correlated with previous 6 months of adherence data</time_frame>
    <description>Anxiety measure - higher scores indicate more anxiety</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Anxiety</condition>
  <condition>ESRD</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Survey</intervention_name>
    <description>For our primary analysis (multiple regression) scores on the GAD-7, BAI and PHQ-9 will be used to predict dialysis adherence, as defined as minutes reduced (total dialysis prescribed -total actual time on machine) while controlling for age and gender.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients receiving treatment at The Rogosin Institute (Rogosin) hemodialysis treatment
        facilities.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Receiving In-center hemodialysis

        Exclusion Criteria:

          -  Non-English speaking
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Daniel Cukor, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Rogosin Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Daniel Cukor, PhD</last_name>
    <phone>646-317-0798</phone>
    <email>dac9227@nyp.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Rogosin Institute</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Cukor, Ph.D.</last_name>
      <phone>646-317-0798</phone>
      <email>dac9227@nyp.org</email>
    </contact>
    <investigator>
      <last_name>Daniel Cukor, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>October 24, 2019</study_first_submitted>
  <study_first_submitted_qc>October 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2019</study_first_posted>
  <last_update_submitted>April 30, 2020</last_update_submitted>
  <last_update_submitted_qc>April 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

